Strumento inattivo

Altre lingue Atlas Cloud Enterprises Inc Canadian Securities Exchange

Azioni

AKE

CA0492371004

Prezzo di chiusura Canadian Securities Exchange Altri mercati azionari
-	-

26/04	Isracann Biosciences Inc. annuncia le dimissioni dei direttori	CI
23/01	Isracann Biosciences Inc. annuncia cambiamenti nella gestione	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Isracann Biosciences Inc. Announces Resignation of Directors	26/04
Isracann Biosciences Inc. Announces Management Changes	23/01
Isracann Biosciences Inc. Appoints Ajay Singh Kaila as Interim CEO	23/01/23
Isracann Biosciences Inc. Announces Resignation of Phil Floucault as Chief Executive Officer	17/01/23
Isracann Biosciences Inc. Announces Resignation of Phil Floucault as Director	17/01/23
Isracann Biosciences Inc. Announces Resignation of James Thompson as Chief Operations Officer	17/01/23
Isracann Biosciences Inc. Announces the Resignation of Irit Arbel as Director	20/12/22
Isracann Biosciences Inc. Reports Earnings Results for the First Quarter Ended August 31, 2022	08/12/22
Isracann Biosciences Inc. Auditor Raises 'Going Concern' Doubt	30/11/22
Isracann Biosciences Inc. Reports Earnings Results for the Full Year Ended May 31, 2022	30/11/22
Isracann Bioscience Inc. Announces Facilitated Genetics Arrive in Israel	28/09/22
Isracann Bioscience Facilitates Cannabis Genetics Shipment to Israel	14/09/22
Isracann Biosciences Inc. Signs Distribution Agreement with Pure Integrative Pharmacy	01/09/22
Isracann Biosciences Inc. Appoints Mark Rypien to Its Advisory Board	23/08/22
Isracann Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	27/04/22
Isracann Biosciences Inc. Announces Executive Changes	20/04/22
Isracann Biosciences Inc. Announces Executive Changes	15/04/22
Isracann Biosciences Inc. Appoints George Vrabec to the Position of Director of Natural Health Products	13/04/22
Isracann Biosciences Inc. completed the acquisition of Praesidio Health Inc.	12/04/22
Isracann Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2021	01/02/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Atlas Cloud Enterprises Inc Canadian Securities Exchange

Azioni

AKE

CA0492371004

Altre lingue

Filtri